Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Coumarin-Resistenz

Ein gesteigertes oder herabgesetztes Ansprechen gegenüber Vitamin-K Antagonisten kann durch eine Reihe unterschiedlicher genetischer Veränderungen bedingt sein.

Gliederung

Genetische Einflüsse auf Arzneimittel-Verträglichkeit
Coumarin-Resistenz
CYP2A6
CYP2C9
CYP4F2
VKORC1
Hepatitis C-Therapieansprechbarkeit
Störungen im Cytochrom P450-System

Referenzen:

1.

Wood AW et al. (1974) Genetic variation in coumarin hydroxylase activity in the mouse (Mus musculus).

external link
2.

Whitlon DS et al. (1978) Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition.

external link
3.

Greavses JH et al. (1967) Heritable resistance to warfarin in rats.

external link
4.

Lewis RJ et al. (1967) Warfarin resistance.

external link
5.

Pool JG et al. (1968) Warfarin resistance in the rat.

external link
6.

None (1970) The second reported kindred with hereditary resistance to oral anticoagulant drugs.

external link
7.

Vesell ES et al. (1968) Genetic control of dicumarol levels in man.

external link
8.

Alving BM et al. (1985) Hereditary warfarin resistance. Investigation of a rare phenomenon.

external link
9.

Nebert DW et al. () The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.

external link
10.

Takeuchi F et al. (2009) A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose.

external link
11.

Borgiani P et al. (2009) CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.

external link
12.

Limdi NA et al. (2008) VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans.

external link
13.

Cooper GM et al. (2008) A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose.

external link
14.

Takahashi H et al. (2006) Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans.

external link
15.

Rost S et al. (2004) Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.

external link
16.

Shikata E et al. (2004) Association of pharmacokinetic (CYP2C9) and pharmacodynamic (factors II, VII, IX, and X; proteins S and C; and gamma-glutamyl carboxylase) gene variants with warfarin sensitivity.

external link
17.

O'REILLY RA et al. (1964) HEREDITARY TRANSMISSION OF EXCEPTIONAL RESISTANCE TO COUMARIN ANTICOAGULANT DRUGS. THE FIRST REPORTED KINDRED.

external link
18.

Lindberg RL et al. (1992) Molecular characterization of the murine Coh locus: an amino acid difference at position 117 confers high and low coumarin 7-hydroxylase activity in P450coh.

external link
19.

Yuan HY et al. (2005) A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

external link
20.

Caldwell MD et al. (2008) CYP4F2 genetic variant alters required warfarin dose.

external link
21.

et al. (2009) Estimation of the warfarin dose with clinical and pharmacogenetic data.

external link
22.

Kohn MH et al. (2000) A gene-anchored map position of the rat warfarin-resistance locus, Rw, and its orthologs in mice and humans.

external link
23.

Lush IE et al. (1978) Genetic variation between mice in their metabolism of coumarin and its derivatives.

external link
24.

Yamano S et al. (1990) The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes.

external link
25.

OMIM.ORG article

Omim 122700 external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz